Registration
HOLLAND & KNIGHT LLP for THE BIOSIMILARS FORUM
Firm
Client
Income
—
Expenses
—
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
Medicare reimbursement issues; FDA regulation of biosimilars.
| Lobbyist | Covered position, as disclosed |
|---|---|
| PAUL S. BOCK New | Chief of Staff, Senator Herb Kohl ; ; Counsel, House Judiciary Committee |
| CHRISTOPHER DELACY New | Counsel, House Science Cmte., Technology Subcmte. ; ; Counsel, Senator John Warner |
| MIRANDA FRANCO New | — |
| RICHARD M GOLD New | — |
| KARL KOCH New | Chief of Staff, Rep. Jim Davis |
| KATHRYN H LEHMAN New | Chief Counsel, Sbcmte. on Constitution, H. Judiciary Cmte. ; ; Special Assistant to Speaker of the House ; ; Policy Director, House Majority Whip ; ; Director of Coalition Outreach, Speaker of House ; ; Chief of Staff, House Republican Conference |
| MICHAEL WERNER New | — |
Medical/Disease Research/Clinical Labs MED
Medicare reimbursement issues; FDA regulation of biosimilars.
| Lobbyist | Covered position, as disclosed |
|---|---|
| PAUL S. BOCK New | Chief of Staff, Senator Herb Kohl ; ; Counsel, House Judiciary Committee |
| CHRISTOPHER DELACY New | Counsel, House Science Cmte., Technology Subcmte. ; ; Counsel, Senator John Warner |
| MIRANDA FRANCO New | — |
| RICHARD M GOLD New | — |
| KARL KOCH New | Chief of Staff, Rep. Jim Davis |
| KATHRYN H LEHMAN New | Chief Counsel, Sbcmte. on Constitution, H. Judiciary Cmte. ; ; Special Assistant to Speaker of the House ; ; Policy Director, House Majority Whip ; ; Director of Coalition Outreach, Speaker of House ; ; Chief of Staff, House Republican Conference |
| MICHAEL WERNER New | — |
Health Issues HCR
Medicare reimbursement issues; FDA regulation of biosimilars.
| Lobbyist | Covered position, as disclosed |
|---|---|
| PAUL S. BOCK New | Chief of Staff, Senator Herb Kohl ; ; Counsel, House Judiciary Committee |
| CHRISTOPHER DELACY New | Counsel, House Science Cmte., Technology Subcmte. ; ; Counsel, Senator John Warner |
| MIRANDA FRANCO New | — |
| RICHARD M GOLD New | — |
| KARL KOCH New | Chief of Staff, Rep. Jim Davis |
| KATHRYN H LEHMAN New | Chief Counsel, Sbcmte. on Constitution, H. Judiciary Cmte. ; ; Special Assistant to Speaker of the House ; ; Policy Director, House Majority Whip ; ; Director of Coalition Outreach, Speaker of House ; ; Chief of Staff, House Republican Conference |
| MICHAEL WERNER New | — |
Medicare/Medicaid MMM
Medicare reimbursement issues; FDA regulation of biosimilars.
| Lobbyist | Covered position, as disclosed |
|---|---|
| PAUL S. BOCK New | Chief of Staff, Senator Herb Kohl ; ; Counsel, House Judiciary Committee |
| CHRISTOPHER DELACY New | Counsel, House Science Cmte., Technology Subcmte. ; ; Counsel, Senator John Warner |
| MIRANDA FRANCO New | — |
| RICHARD M GOLD New | — |
| KARL KOCH New | Chief of Staff, Rep. Jim Davis |
| KATHRYN H LEHMAN New | Chief Counsel, Sbcmte. on Constitution, H. Judiciary Cmte. ; ; Special Assistant to Speaker of the House ; ; Policy Director, House Majority Whip ; ; Director of Coalition Outreach, Speaker of House ; ; Chief of Staff, House Republican Conference |
| MICHAEL WERNER New | — |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| SAMSUNG BIOEPIS | South Korea | South Korea | 100.0% | — |
| BOEHRINGER INGELHEIM GMBH | Germany | Germany | 100.0% | — |
| TEVA PHARMACEUTICAL INDUSTRIES LTD. | Israel | Israel | 100.0% | — |
| MERCK KGAA | Germany | Germany | 100.0% | — |
| NOVARTIS AG | Switzerland | Switzerland | 100.0% | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.